Fact CheckerSign in

NCT05961371Active, not recruiting

Strength Training for Osteoporosis Prevention During Early Menopause

Source: ClinicalTrials.gov · Last updated 5 Dec 2024

Brief summary (registry, in English)

The goal of this clinical pilot trial is to learn about the feasibility of a high-intensity resistance training intervention in peri- and early menopausal females. The main question it aims to answer are: -Is a 9-month resistance training intervention feasible (e.g., recruitment rates, protocol adherence, attrition) Secondary aims include examining changes in bone health, muscle strength, and menopausal symptoms. Participants will participate in a 9-month progressive, supervised, resistance training intervention. Researchers will compare secondary outcomes between the exercise group and a wait-list control group.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
26 Jun 2023
Start date
1 Nov 2023
Primary completion date
Feb 2025
Lead sponsor
University of Calgary
Diseases
Osteoporosis
NCT number
NCT05961371

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Nov 2023 to the primary completion date, Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Had previous treatment with osteoporosis pharmacotherapy.
  • Is currently participating in progressive resistance training or has in the previous 6 months.

Other illness

  • Orthopaedic conditions that may be made worse with exercise.
  • Has low back pain, hypertension, lipidemia, diabetes, or cardiovascular disease.
  • Has a history of metabolic bone disease.

Lab values

  • Has low serum vitamin D (25(OH)D) \< 30 nmol/L or serum calcium \<2.10 mmol/L.

Other

  • Females who are pregnant or planning pregnancy within the next year.
  • Has had an osteoporotic fracture within the last 5 years.
  • Has active glucocorticoid use.

Who the study is looking for

  • 45-60 years old.
  • Menopause status of peri- or early menopausal: stages -2 or -1 of the stages for reproductive aging 10+ staging system or are within 5 years of their last known menses.

Age in the registry: 45 years to 60 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Of Calgary
Coordinator of this site? Confirm its status
CalgaryCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.